While not contraindicated, BPC-157 may actually reduce or eliminate the need for NSAIDs as it addresses inflammation through growth factor modulation rather than COX inhibition. Some research suggests NSAIDs may slightly impair the healing mechanisms BPC-157 promotes. A study in
Bone & Joint Research indicates that NSAIDs can delay tendon healing, so many users taper off NSAIDs when starting BPC-157.